https://www.selleckchem.com/pr....oducts/senaparib.htm
Overall, we suggested that DNAJC24 may become a new target for the treatment of HCC.Anti-angiogenic cancer therapies possess immune-stimulatory properties by counteracting pro-angiogenic molecular mechanisms. We report that tumor endothelial cells ubiquitously overexpress and secrete the intermediate filament protein vimentin through type III unconventional secretion mechanisms. Extracellular vimentin is pro-angiogenic and functionally mimics VEGF action, while concomitantly acting as inhibitor of leukocyte-endothelial interactions. A
Like
Comment
Share
